Deutsche Bank Swings to Profit, Lowers Bad-Loan Provisions
The lender returned to a third-quarter profit, beating expectations as it benefited from strong performance in investment banking and a faster-than-anticipated recovery in its home market.
Bayer, BASF Weedkillers Cleared by EPA for Another Five Years
The agency said its reapproval of dicamba herbicides, which have been blamed for damaging millions of acres of crops in recent years, would provide clarity to farmers who say they need the spray to combat hard-to-kill weeds.
Sony's Second-Quarter Net Profit More Than Doubled
Sony's second-quarter net profit more than doubled from a year earlier thanks to greater earnings from its game business and a drop in tax expenses.
Heineken to Buy Strongbow Cider Brand
Heineken will buy cider brand Strongbow from Asahi in Australia, after the Japanese firm put up those assets for sale to meet regulatory requirements.
Revlon Warns of Possible Bankruptcy Reorganization if Bond Swap Flops
The beauty-products maker warned bondholders about the substantial risk of a bankruptcy restructuring if they don't participate in a proposed debt exchange.
Equitable Reaches Deal With Venerable to Reinsure $12 Billion in Annuities
Equitable has entered an agreement with Venerable for the privately held company to reinsure 114,000 variable-annuity policies sold between 2006 and 2008.
Purdue Creditors Committee Criticizes U.S. Deal With Sackler Family
The federal government's proposed settlement with the Sackler family members who own OxyContin maker Purdue Pharma ran into opposition from company creditors worried that less money will be left over for them.
Microsoft Continues to Ride Virus-Fueled Demand for Cloud
The software company expects the pandemic-era surge in demand for cloud-computing services, videogaming and computers that delivered a solid quarter to persist at least through the rest of the year.
Visa's Planned Purchase of Plaid Faces Antitrust Scrutiny at the Justice Department
The DOJ, making preparations for potential litigation, could soon decide whether it will sue to block Visa's purchase of the fintech firm.
Eli Lilly Earnings, Halted Covid-19 Drug Trial Disappoint Investors
The drugmaker reported lower-than-expected quarterly earnings due to pricing pressure on top products. It said it would proceed with plans to introduce a new coronavirus antibody treatment despite a recent setback.
(END) Dow Jones Newswires